Andersons pediatric cardiology 1798
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.33 KB, 3 trang )
Internationalsocietyforheartandlung
transplantationworkingformulationofa
standardizednomenclatureforcardiacallograft
vasculopathy–2010.JHeartLungTransplant.
2010;29(7):717–727.
75.PotenaL,MasettiM,SabatinoM,etal.Interplay
ofcoronaryangiographyandintravascular
ultrasoundinpredictinglong-termoutcomes
afterhearttransplantation.JHeartLung
Transplant.2015;34:1146–1153.
76.MirelisJG,Garcia-PavlaP,CaveroMA,etal.
Magneticresonancefornon-invasivedetection
ofmicrocirculatorydiseaseassociatedwith
allograftvasculopathy:intracoronary
measurementsvalidation.RevEspCardiol(Engl
Ed).2015;68:571–578.
77.TomaiF,DeLucaL,PetroliniA,etal.Optical
coherencetomographyforcharacterizationof
cardiacallograftvasculopathyinlatesurvivors
ofpediatrichearttransplantation.JHeartLung
Transplant.2016;35:74–79.
78.KobashigawaJA,KatznelsonS,LaksH,etal.
Effectofpravastatinonoutcomesaftercardiac
transplantation.NEnglJMed.1995;333:621–
627.
79.WenkeK,MeiserB,ThieryJ,etal.Simvastatin
reducesgraftvesseldiseaseandmortalityafter
hearttransplantation:afour-yearrandomized
trial.Circulation.1997;96:1398–1402.
80.MahleWT,VincentRN,BergAM,etal.
Pravastatintherapyisassociatedwithreduction
incoronaryallograftvasculopathyinpediatric
hearttransplantation.JHeartLungTransplant.
2005;24:63–66.
81.ChinC,GambergP,MillerJ,etal.Efficacyand
safetyofatorvastatinafterpediatricheart
transplantation.JHeartLungTransplant.
2002;21:1213–1217.
82.GreenwaySC,ButtsR,NaftelDC,etal.Statin
therapyisnotassociatedwithimproved
outcomesafterhearttransplantationinchildren
andadolescents.JHeartLungTransplant.
2016;35:457–465.
83.JeewaA,ChinC,PahlE,etal.Outcomesafter
percutaneouscoronaryarteryrevascularization
proceduresforcardiacallograftvasculopathyin
pediatrichearttransplantrecipients:amultiinstitutionalstudy.JHeartLungTransplant.
2015;34:1163–1168.
84.ShaddyRE,RevenaughJA,OrsmondGS,Tani
LY.Coronaryinterventionalproceduresin
pediatrichearttransplantrecipientswithcardiac
allograftvasculopathy.AmJCardiol.
2000;85:1370–1372.
85.ThamEB,YeungAC,ChengCW,etal.
Experienceofpercutaneouscoronary
interventioninthemanagementofpediatric
cardiacallograftvasculopathy.AmJCardiol.
2005;24:769–773.
86.ConwayJ,DipchandAI.Challengeswith
sensitizedrecipientsinpediatricheart
transplantation.Clinics(SaoPaulo).
2014;69(suppl1):17–21.
87.AbarbanellG,MullaN,ChinnockR,LarsenR.
Exerciseassessmentininfantsaftercardiac
transplantation.JHeartLungTransplant.
2004;23:1334–1338.
88.HsuDT,GarofanoRP,DouglasJM,etal.
Exerciseperformanceafterpediatricheart
transplantation.Circulation.1993;88:II238–
II242.
89.BengalFM,UberfuhrP,SchiepelN,etal.Effect
ofsympatheticreinnervationoncardiac
performanceafterhearttransplantation.NEnglJ
Med.2001;345:731–738.
90.BengalFM,UberfuhrP,HesseT,etal.Clinical
determinantsofventricularsympathetic
reinnervationafterorthotopicheart
transplantation.Circulation.2002;106:831–835.
91.MarconiC,MarzoratiM,FiocchiR,etal.Agerelatedheartrateresponsetoexerciseinheart
